Pharmacy groups respond to a final drug pricing rule without DIR reform, why patients decline statins, rural organizations get $240 million to fight opioid use, and more.
CMS finalizes a rule to include list prices in TV drug ads, Medicare Advantage beneficiaries could save millions thanks to pending telehealth rules, and more news to know.
The value of OTCs to healthcare, the rise of specialty drug spending in Medicare Part D, CMS to test integrated care models for dual eligible beneficiaries, and more industry news to know.
The FDA grants final approval to the first generic naloxone nasal spray, Medicare and Social Security face uncertain financial futures, how Americans feel about ACA protections, and more industry news to know.
In recent months, generic effective rate (GER) clauses in pharmacy contracts have taken center stage as pharmacists become more aware of what exactly this means for them. Though not new, in recent years, GERs have become tighter and more restrictive, leading to the potential for unexpectedly high clawbacks by PBMs at the end of a contract year. Such clauses have shown up in several contracts so far this year, indicating a trend which pharmacists would do well to pay attention to.
As contracts are typically brokered between PSAOs and PBMs, not every pharmacy is or will be affected by GERs. With that in mind, here’s what you need to know about GERs and how they can affect your business.
The measles outbreak is still going strong, U.S. officials are awarding $350 million for research toward ending the opioid epidemic, patient influencers don’t trust pharma websites for health information, and more industry news from the past week.
Last week, executives from the five largest PBMs — CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare’s OptumRx — appeared at a Senate Finance Committee hearing to discuss their roles in pharmaceutical supply chain. The high price of prescription drugs has become a rare bipartisan issue.
PBMs say Big Pharma is responsible for high drug prices, Alexa has new HIPAA-compliant skills, D-SNP look-alike plans may soon be at risk, and more industry news from the past week.
To stay competitive, pharmacies often expand their focus beyond prescriptions to the benefit of both their patients and their bottom lines. In this Q&A, Chris Cornelison, Pharm.D, owner of Iuka Discount Drugs, Saltillo Pharmacy and Solutions, New Albany Pharmacy, and Solutions Rx sheds light on his pharmacy’s experiences with OTC proucts. Read on to see how he educates patients about supplements, how his patients have responded to CBD products, and what he sees driving front-end growth at pharmacies.
Here’s the latest in the world of pharmacy and healthcare:
1. The FDA wants to hear stakeholder experiences with CBD products.
2. The global telemedicine market will hit $130.5 billion by 2025.
3. CMS has introduced new policies to help fight the opioid crisis.
4. CMS has also finalized payment updates to Medicare and Part D plans for 2020.
5. Medicare customers are increasingly looking online for their plans.